Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model

Publication date: May 2021Source: Molecular Immunology, Volume 133Author(s): Ali Uslu, Osman Erganis
Source: Molecular Immunology - Category: Allergy & Immunology Source Type: research